Coronary heart disease is one of the most serious diseases that endanger people's health. Complex coronary artery disease is critical and has high mortality. Therefore, it is urgent to explore the best treatment method for complex coronary artery disease. Some previous studies have shown that patients with left main coronary artery disease with a SYNTAX score\> 32 points, and diabetic/non-diabetic three-vessel disease patients with coronary heart disease with a SYNTAX score \> 22 points, CABG is recommended for revascularization. However, with the continuous innovation of surgical technology and the rapid development of surgical instruments, the treatment of patients with complex coronary artery disease is increasing. Therefore, it is necessary to investigate the effects of different revascularization strategies on long-term prognosis in patients with complex coronary artery disease (SYNTAX score \> 22 points).
Study Type
OBSERVATIONAL
Enrollment
2,864
The procedures include PCI, CABG and HCR
MACCE
Major adverse cardiovascular and cerebrovascular events (MACCE) at 1 year, including all-cause death, non-fatal myocardial infarction, ischemia-driven revascularization, and non-fatal stroke
Time frame: 1 year
All cause death
All-cause death is defined as death from cardiovascular causes, death from non-cardiovascular causes, and death from unknown causes.
Time frame: 1 year
Cardiovascular death
Cardiovascular death
Time frame: 1 year
Non-fatal myocardial infarction
Non-fatal myocardial infarction
Time frame: 1 year
Ischemia-driven revascularization
Ischemia-driven revascularization
Time frame: 1 year
Non-fatal stroke
Stroke is defined as a neurological deficit with symptoms or signs that last at least 24 hours and imaging studies (CT or MRI) confirm the presence of cerebral infarction or cerebral hemorrhage.
Time frame: 1 year
The composite endpoints including all-cause death, non-fatal myocardial infarction, and ischemia-driven revascularization
The composite endpoints including all-cause death, non-fatal myocardial infarction, and ischemia-driven revascularization
Time frame: 1 year
The composite endpoints including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
The composite endpoints including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
Time frame: 1 year
The composite endpoints including cardiovascular death or nonfatal myocardial infarction
The composite endpoints including cardiovascular death or nonfatal myocardial infarction
Time frame: 1 year
All bleeding events defined by the BARC bleeding criteria
All bleeding events defined by the BARC bleeding criteria
Time frame: 1 year
Type 2, 3 and 5 bleeding events defined by the BARC bleeding criteria
Type 2, 3 and 5 bleeding events defined by the BARC bleeding criteria
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.